MyoKardia, Inc. et al v. Apotex Inc. et al
| MyoKardia, Inc. and Bristol-Myers Squibb Company |
| Apotex Inc. and Apotex Corp. |
| 1:2026cv00853 |
| July 14, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 15, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to Apotex Corp. on 7/15/2026; Apotex Inc. on 7/15/2026. (Attachments: #1 Summons Issued)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Company for MyoKardia, Inc. - filed by Bristol-Myers Squibb Company, MyoKardia, Inc. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE50,050 E. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/10/2026. Date of Expiration of Patent: 04/28/2036.Thirty Month Stay Deadline: 10/28/2029. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-5016040) - filed by Bristol-Myers Squibb Company, MyoKardia, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
